Melatonin: A potent antioxidant agent with anti-inflammatory and anti-apoptotic effects that might be useful in the treatment of IBD patients

Annals of Gastroenterology

Volumn 22, Issue 1, 2009, Pages 10-12

  Triantafillidis, Aikaterini ^a,c   Triantafillidis, John K ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Saint Panteleimon General Hospital   (Greece)

^c NONE   (Greece)

Author keywords

Crohn's disease; Inflammatory bowel disease; Melatonin; Treatment; Ulcerative colitis

Indexed keywords

CASPASE 3; GELATINASE A; GELATINASE B; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; MELATONIN; MYELOPEROXIDASE; NITRIC OXIDE; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BACTERIAL TRANSLOCATION; CROHN DISEASE; EDITORIAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOSTIMULATION; NONHUMAN; OXIDATIVE STRESS; ULCERATIVE COLITIS;

EID: 67651113410     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Nosálová V, Zeman M, Cerná S, Navarová J, Zakálová M. Protective effect of melatonin in acetic acid induced colitis in rats. J Pineal Res 2007;42:364-370.
2. Terry PD, Villinger F, Bubenik GA, Sitaraman SV. Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research. Inflamm Bowel Dis 2008 Jul 14. [Epub ahead of print]
3. Konturek SJ, Konturek PC, Brzozowska I, et al. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol. 2007; 58:381-405.
4. Mei Q, Xu JM, Xiang L, Hu YM, Hu XP, Xu ZW. Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J 2005; 81:667-672.
5. Dong WG, Mei Q, Yu JP, Xu JM, Xiang L, Xu Y. Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis. World J Gastroenterol. 2003; 9:1307-1311.
6. Wu CC, Chiao CW, Hsiao G, Chen A, Yen MH. Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res 2001;30:147-156.
7. Worledge KL, Godiska R, Barrett TA, Kink JA. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats. Dig Dis Sci 2000; 45:2298-2305.
8. Triantafillidis JK, A. Papalois, A. Parassi, et al. Favorable response to subcutaneous administration of Infliximab in experimental colitis in rats. World J Gastroenterol 2005; 11:6843-6847.
9. Esposito E, Mazzon E, Riccardi L, Caminiti R, Meli R, Cuzzocrea S. Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. J Pineal Res 2008; 45:166-173.
10. Wang H, Xu DX, Lv JW, Ning H, Wei W. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice. Toxicology 2007; 237:49-57
11. Akcan A, Kucuk C, Sozuer E, Esel D, Akyildiz H, Akgun H, Muhtaroglu S, Aritas Y. Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats. World J Gastroenterol 2008; 14:918-924.
12. Sasaki M, Jordan P, Joh T, Itoh M, Jenkins M, Pavlick K, Minagar A, Alexander SJ. Melatonin reduces TNF-a induced expression of MAdCAM-1 via inhibition of NF-kappaB. BMC Gastroenterol 2002; 2:9.
13. Marquez E, Sánchez-Fidalgo S, Calvo JR, la de Lastra CA, Motilva V. Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis. J Pineal Res 2006; 40:48-55.